Crossmark Global Holdings, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,077
-99.9%
18,928
-18.1%
0.03%
+8.0%
Q3 2022$914,000
-12.6%
23,122
-2.8%
0.02%
-7.4%
Q2 2022$1,046,000
-1.1%
23,776
-10.4%
0.03%
+12.5%
Q1 2022$1,058,000
+19.1%
26,526
+20.2%
0.02%
+26.3%
Q4 2021$888,000
+7.5%
22,076
+8.7%
0.02%0.0%
Q3 2021$826,000
-10.2%
20,316
+0.2%
0.02%
-13.6%
Q2 2021$920,000
+8.7%
20,270
-0.1%
0.02%
+4.8%
Q1 2021$846,000
-0.8%
20,300
+1.7%
0.02%
-4.5%
Q4 2020$853,00019,9700.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders